Cencora, Inc. · Drugs, Proprietaries & Druggists' Sundries

COR

Low riskNext report: Around Feb 3, 2027 (est.)

View price ↗

The short version

A profitable company with steady sales.

Going well

Profitable
Brings in more cash than it spends
Buying back shares: share count down 7.6% in 3 years

Watch out for

High debt: 4.15x equity

Money moves

Insiders sold $299K in the last 30 days, all through pre-planned sales
Institutions added 0.4% to their holdings in the quarter ending June 2026 (525 bought, 790 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$330.28-0.2% that day

Company value: $63.0B; Share price times all shares
Price vs profit (P/E): 24.5x; You pay about $25 for each $1 of yearly profit
Price vs sales: 0.19x; Company value is 0.19 times a year of sales
Dividend yield: 0.7%; Yearly dividend as a share of today's price
Cash vs value: 4%; Cash as a share of company value
Debt vs value: 13%; Debt as a share of company value

From COR's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$84.8B+5.1% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $332.8B, up 5.1% from the 12 months before. Over 5 years, sales grew about 11% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of COR. Starting points are the company's recent numbers.

Sales growth+5% a yearRecently: +5.1% a yearProfit margin1%Last 12 months: 0.8%P/E at the end25xToday: 24.5x. Many steady companies trade at 12x to 25xShare count change-3% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$424.7B

Profit in 5 years$4.2B

Price these guesses point to$647.94+96% vs $330.28 todayAbout +14% a year, before dividends

What today's price needs: with a 1% margin and a 25x P/E, sales could shrink about 8.2% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/7Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.145.6%
MissDebt under half of equityNot relying on borrowed money.4.15x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.0.5%
MissProfitable every yearSteady profits, not one good year.9 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$3.2B
PassShare count not growingNot diluting owners. Falling means buybacks.-7.6% in 3 years
MissGross margin 40%+Pricing power: sells for well above what it costs to make.3.6%

Revenue: $321.3B; +9.3% vs prior year
5-year growth: +11.1%/yr; revenue, per year
Total debt: $7.9B; 4.15x equity
Current ratio: 0.92x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.

Latest quarter

New results, as stated in the press release

Reported Oct 21Before open7:48 am ET

EPS: $17.90

Revenue and EPS as the company states them. Margins, cash flow and share count fill in with the 10-Q.

Insider rating

Last 90 days

46Mixed

Pre-planned sales of $299K (weaker signal)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

38/ 100

This week: 1
Normal week: 1.7
vs normal: 0.6x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady+0.4%

Institutions added 0.4% to their holdings. 525 bought, 790 sold.

Shares held by institutions183.6M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-1.9%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

3.8x · $11.7B debt

Shares outstandingLatest reported

191M

Why low risk

High debt: 3.84x equity

Earnings reports

Last 12

Next reportAround Feb 3, 2027 (est.)Estimated from the same quarter last year

Results filedOct 21
Results filedAug 5
Results filedMay 6
Results filedFeb 4
Results filedNov 5, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

No offerings, red flags or new big holders. Clean record.

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$299K1 insider, 1 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Lazarus KrikorianSVP & Chief Accounting Officer	Sell	986	$303.18	$299K	15K	Oct 1Filing ↗
-6.1% of their holdings Pre-planned sale (10b5-1) Filed 4 days after